18 research outputs found
Secretion rates and protein composition of extracellular vesicles released by cancer-associated fibroblasts after radiation
Reciprocal communication between the malignant and non-malignant cellular elements in tumors is essential for cancer sustainability and plays an important role in the response of cancers to treatments. Some of this cellular crosstalk takes place via secretion of vesicles that are actively released into the extracellular space by most cell types in tumors. Recent studies have demonstrated radiation-induced changes in the secretion rate and composition of extracellular vesicles (EVs), with impact on radiation-related cellular communication. However, little is known about the effects of different radiation regimens on the release of EVs by cells of the tumor microenvironment. In this study, we provide a comprehensive molecular characterization of EVs released by cultured primary lung tumor fibroblasts. We explore the quantitative and morphological changes triggered by ionizing radiation (IR), delivered as a single dose of 18 Gy or three consecutive daily medium-doses of 6 Gy. Cancer-associated fibroblasts (CAFs) secrete EVs with sizes ranging from 80 to 200 nm, expressing some of the classical exosome markers. Exposing CAFs to a single-high radiation dose (1 × 18 Gy) or fractionated medium-dose did not alter the release of CAF-EVs. The protein composition of CAF-EVs was analyzed by LC-MS/MS proteomics and revealed that CAF-EVs are enriched with heat shock proteins, integrins, tetraspanins, proteinases, collagens, growth factors and an array of molecules involved in the regulation of cell migration and the immune system. Quantitative proteomic analyses revealed minor changes in the protein composition of CAF-EVs after radiation exposure. Taken together, this study presents original data on lung tumor CAF-EV composition and reveals that release and protein cargo of CAF-EVs are largely unaltered after exposing CAFs to IR
Changes in the proteome and secretome of rat liver sinusoidal endothelial cells during early primary culture and effects of dexamethasone
Introduction
Liver sinusoidal endothelial cells (LSECs) are specialized fenestrated scavenger endothelial
cells involved in the elimination of modified plasma proteins and tissue turnover waste macromolecules from blood. LSECs also participate in liver immune responses. A challenge
when studying LSEC biology is the rapid loss of the in vivo phenotype in culture. In this
study, we have examined biological processes and pathways affected during early-stage
primary culture of rat LSECs and checked for cell responses to the pro-inflammatory cytokine interleukin (IL)-1β and the anti-inflammatory drug dexamethasone.
Methods
LSECs from male Sprague Dawley rats were cultured on type I collagen in 5% oxygen atmosphere in DMEM with serum-free supplements for 2 and 24 h. Quantitative proteomics
using tandem mass tag technology was used to examine proteins in cells and supernatants.
Validation was done with qPCR, ELISA, multiplex immunoassay, and caspase 3/7 assay.
Cell ultrastructure was examined by scanning electron microscopy, and scavenger function
by quantitative endocytosis assays.
Results
LSECs cultured for 24 h showed a characteristic pro-inflammatory phenotype both in the
presence and absence of IL-1β, with upregulation of cellular responses to cytokines and
interferon-γ, cell-cell adhesion, and glycolysis, increased expression of fatty acid binding
proteins (FABP4, FABP5), and downregulation of several membrane receptors (STAB1,
STAB2, LYVE1, CLEC4G) and proteins in pyruvate metabolism, citric acid cycle, fatty acid elongation, amino acid metabolism, and oxidation-reduction processes. Dexamethasone
inhibited apoptosis and improved LSEC viability in culture, repressed inflammatory and
immune regulatory pathways and secretion of IL-1β and IL-6, and further upregulated
FABP4 and FABP5 compared to time-matched controls. The LSEC porosity and endocytic
activity were reduced at 24 h both with and without dexamethasone but the dexamethasone-treated cells showed a less stressed phenotype.
Conclusion
Rat LSECs become activated towards a pro-inflammatory phenotype during early culture.
Dexamethasone represses LSEC activation, inhibits apoptosis, and improves cell viability
Cleavage of the urokinase receptor (uPAR) on oral cancer cells : regulation by transforming growth factor - beta 1 (TGF-beta 1) and potential effects on migration and invasion
Background: Urokinase plasminogen activator (uPA) receptor (uPAR) is up-regulated at the invasive tumour front of human oral squamous cell carcinoma (OSCC), indicating a role for uPAR in tumour progression. We previously observed elevated expression of uPAR at the tumour-stroma interface in a mouse model for OSCC, which was associated with increased proteolytic activity. The tumour microenvironment regulated uPAR expression, as well as its glycosylation and cleavage. Both full-length- and cleaved uPAR (uPAR (II-III)) are involved in highly regulated processes such as cell signalling, proliferation, migration, stem cell mobilization and invasion. The aim of the current study was to analyse tumour associated factors and their effect on uPAR cleavage, and the potential implications for cell proliferation, migration and invasion. Methods: Mouse uPAR was stably overexpressed in the mouse OSCC cell line AT84. The ratio of full-length versus cleaved uPAR as analysed by Western blotting and its regulation was assessed by addition of different protease inhibitors and transforming growth factor - beta 1 (TGF-beta 1). The role of uPAR cleavage in cell proliferation and migration was analysed using real- time cell analysis and invasion was assessed using the myoma invasion model. Results: We found that when uPAR was overexpressed a proportion of the receptor was cleaved, thus the cells presented both full-length uPAR and uPAR (II-III). Cleavage was mainly performed by serine proteases and urokinase plasminogen activator (uPA) in particular. When the OSCC cells were stimulated with TGF-beta 1, the production of the uPA inhibitor PAI-1 was increased, resulting in a reduction of uPAR cleavage. By inhibiting cleavage of uPAR, cell migration was reduced, and by inhibiting uPA activity, invasion was reduced. We could also show that medium containing soluble uPAR (suPAR), and cleaved soluble uPAR (suPAR (II-III)), induced migration in OSCC cells with low endogenous levels of uPAR. Conclusions: These results show that soluble factors in the tumour microenvironment, such as TGF-beta 1, PAI-1 and uPA, can influence the ratio of full length and uPAR (II-III) and thereby potentially effect cell migration and invasion. Resolving how uPAR cleavage is controlled is therefore vital for understanding how OSCC progresses and potentially provides new targets for therapy.Peer reviewe
Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: a laboratory study using an in vitro model
Additional file 1: Figure S1. of Co-expression of 1α-hydroxylase and vitamin D receptor in human articular chondrocytes
qPCR. Relative expression of cartilage signature genes in donor matched suspension- and monolayer culture samples from three donors. Suspension cultures samples were challenged with vehicle, 1α,25(OH)2D2 or 1α,25(OH)2D3 at 10-8 M for 24 hours. The qPCR reaction was setup as described in material and methods. Collagen type IX alpha 1 chain (COL9A1, Hs00932129_m1) and collagen typeX alpha 1 chain (COL10A1, Hs00166657_m1) hydrolysis probes (Life Technologies by Fisher Scientific) were included in addtion to probes listed previously. The dCq was calculated by subtracting the reference gene from the gene of interest so that a higher dCq value represents an upregulation and vice versa. Delta Cq values were mean-centred and autoscaled, and normalized to a suspension culture control sample to obtain ddCq [1]. A Dunnett’s test was used to compare the treated suspension cultures samples and the untreated monolayer samples to the suspension culture control sample. Error bars represent 95 % confidence intervals. References 1. Willems E, Leyns L, Vandesompele J. Standardization of real-time PCR gene expression data from independent biological replicates. Anal Biochem. 2008;379:127–9. doi:10.1016/j.ab.2008.04.036. (EPS 912 kb
Ionizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts
Cancer-associated fibroblasts (CAFs) are abundantly present in solid tumors and affect tumorigenesis and therapeutic responses. In the context of clinical radiotherapy, the impact of irradiated CAFs to treatment outcomes is largely unexplored. Aiming at improving radiotherapy efficacy, we have here explored the effect of radiation on the inherent pro-tumorigenic capacity of CAFs in animals. Ionizing radiation was delivered to cultured CAFs as single-high or fractionated doses. Tumor development was compared in mice receiving A549 lung tumor cells admixed with irradiated or control CAFs. Biological mechanisms behind tumor growth regulation were investigated by quantitative histology and immunohistochemistry. Viability assessments confirmed that irradiated CAFs are fully functional prior to implantation. However, the enhanced tumorigenic effect observed in tumors co-implanted with control CAFs was abrogated in tumors established with irradiated CAFs. Experiments to ascertain fate of implanted fibroblasts showed that exogenously administered CAFs reside at the implantation site for few days, suggesting that tumor growth regulation from admixed CAFs take place during initial tumor formation. Our work demonstrate that irradiated CAFs lose their pro-tumorigenic potential in vivo, affecting angiogenesis and tumor engraftment. This finding propose a previously unknown advantageous effect induced by radiotherapy, adding to the direct cytotoxic effects on transformed epithelial cells
In vitro chondrogenic potency of surplus chondrocytes from autologous transplantation procedures does not predict short-term clinical outcomes
Abstract Background Autologous chondrocyte implantation (ACI) has been used over the last two decades to treat focal cartilage lesions aiming to delay or prevent the onset of osteoarthritis; however, some patients do not respond adequately to the procedure. A number of biomarkers that can forecast the clinical potency of the cells have been proposed, but evidence for the relationship between in vitro chondrogenic potential and clinical outcomes is missing. In this study, we explored if the ability of cells to make cartilage in vitro correlates with ACI clinical outcomes. Additionally, we evaluated previously proposed chondrogenic biomarkers and searched for new biomarkers in the chondrocyte proteome capable of predicting clinical success or failure after ACI. Methods The chondrogenic capacity of chondrocytes derived from 14 different donors was defined based on proteoglycans staining and visual histological grading of tissues generated using the pellet culture system. A Lysholm score of 65 two years post-ACI was used as a cut-off to categorise “success” and “failure” clinical groups. A set of predefined biomarkers were investigated in the chondrogenic and clinical outcomes groups using flow cytometry and qPCR. High-throughput proteomics of cell lysates was used to search for putative biomarkers to predict chondrogenesis and clinical outcomes. Results Visual histological grading of pellets categorised donors into “high” and “low” chondrogenic groups. Direct comparison between donor-matched in vitro chondrogenic potential and clinical outcomes revealed no significant associations. Comparative analyses of selected biomarkers revealed that expression of CD106 and TGF-β-receptor-3 was enhanced in the low chondrogenic group, while expression of integrin-α1 and integrin-β1 was significantly upregulated in the high chondrogenic group. Additionally, increased surface expression of CD166 was observed in the clinical success group, while the gene expression of cartilage oligomeric matrix protein was downregulated. High throughput proteomics revealed no differentially expressed proteins from success and failure clinical groups, whereas seven proteins including prolyl-4-hydroxylase 1 were differentially expressed when comparing chondrogenic groups. Conclusion In our limited material, we found no correlation between in vitro cartilage-forming capacity and clinical outcomes, and argue on the limitations of using the chondrogenic potential of cells or markers for chondrogenesis as predictors of clinical outcomes
Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: A laboratory study using an in vitro model
Background:
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a bleeding disorder caused by maternal
antibodies against paternal human platelet antigens (HPAs) on fetal platelets. Antibodies against HPA-1a are
accountable for the majority of FNAIT cases. We have previously shown that high levels of maternal anti-HPA-1a
antibodies are associated with clinically significant reduced birth weight in newborn boys. Chronic inflammatory
placental lesions are associated with increased risk of reduced birth weight and have previously been reported in
connection with FNAIT pregnancies. The HPA-1a epitope is located on integrin
β
3 that is associated with integrin
α
IIb (the fibrinogen receptor) on platelets and megakaryocytes. Integrin
β
3 is also associated with integrin
α
V
forming the
α
V
β
3 integrin heterodimer, the vitronectin receptor, which is expressed on various cell types, including
trophoblast cells. It is therefore thinkable that maternal anti-HPA-1a antibodies present during early pregnancy may
affect placenta function through binding to the HPA-1a antigen epitope on invasive throphoblasts. The aim of the
study was to examine whether interaction of a human anti-HPA-1a monoclonal antibody (mAb) with HPA-1a on
trophoblast cells affect adhesion, migration and invasion of extravillous trophoblast cells.
Methods:
An in vitro model with human anti-HPA-1a mAb, clone 26.4, and the first trimester extravillous trophoblast
cell line HTR8/SVneo was employed. The xCELLigence system was utilized to assess the possible effect of anti-HPA-1a
mAb on adhesion and migration of HTR8/SVneo cells. Specially designed chambers precoated with Matrigel were used
to assess the effect on the invasive capacity of cells.
Results:
We found that human anti-HPA-1a mAb 26.4 partia
lly inhibits adhesion and migratory capacity of
HTR8/SVneo cells.
Conclusions:
Our findings suggest that anti-HPA-1a antibodies may affect trophoblast functions crucial for normal placental development. Future studies including
primary throphoblast cells and polyclonal anti-HPA-1a
antibodies are needed to confirm these results
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer
<div><p>Objectives</p><p>Selective targeting of cancer-associated fibroblasts (CAFs) has been proposed to synergize with immune-checkpoint inhibitors. While the roles of CAFs in cancer development are well described, their immune-regulatory properties remain incompletely understood. This study investigates correlations between CAF and immune-markers in tumor stroma from non-small cell lung cancer (NSCLC) patients, and examines whether a combination of CAF and immune cell scores impact patient prognosis.</p><p>Methods</p><p>Tumor specimens from 536 primary operable stage I-III NSCLC patients were organized in tissue microarrays. Expression of protein-markers was evaluated by immunohistochemistry.</p><p>Results</p><p>Fibroblast and stromal markers PDGFRα, PDGFRβ, FAP-1 and vimentin showed weak correlations while αSMA, and Masson’s trichrome did not correlate with any of the investigated markers. Hierarchical clustering indicated the existence of different CAF-subsets. No relevant correlations were found between any CAF-marker and the immune-markers CD3, CD4, CD8, CD20, CD68, CD1a, CD56, FoxP3 and CD45RO. High density of fibroblast-activation protein positive mesenchymal cells (CAF<sup>FAP</sup>) was associated with better prognosis in tumors with high infiltration of CD8 and CD3 T-lymphocytes.</p><p>Conclusions</p><p>The presented data suggest that CAFs, irrespective of identity, have low influence on the degree of tumor infiltration by inflammatory- and/or immune-cells. However, CAF<sup>FAP</sup> may exert immuno-adjuvant roles in NSCLC, and targeting CAFs should be cautiously considered.</p></div
Multivariable models of FAP1 (A-D) and PDGFRβ (E-H) predicting survival of NSCLC patients with high and low expression of CD8 (A, C, E and G) and CD3 (B D, F and H, Cox regression analysis).
<p>Multivariable models of FAP1 (A-D) and PDGFRβ (E-H) predicting survival of NSCLC patients with high and low expression of CD8 (A, C, E and G) and CD3 (B D, F and H, Cox regression analysis).</p